Search Results - Limor Rubin

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    A unique case of IUD associated group A Streptococci pyogenic ascites by Smadar Goldfarb, Maya Korem, Limor Rubin

    Published in IDCases (2025-01-01)
    Get full text
    Article


  2. 2

    Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity by Lijun Ge, Shuyuan Liu, Limor Rubin, Philip Lazarovici, Wenhua Zheng

    Published in Cells (2022-02-01)
    Get full text
    Article


  3. 3

    Administration of BNT162b2 mRNA COVID-19 vaccine to subjects with various allergic backgrounds by Yaarit Ribak, Limor Rubin, Aviv Talmon, Zvi Dranitzki, Oded Shamriz, Isca Hershkowitz, Yuval Tal, Alon Y. Hershko

    Published in Frontiers in Immunology (2023-08-01)
    Get full text
    Article


  4. 4

    Rasagiline Exerts Neuroprotection towards Oxygen–Glucose-Deprivation/Reoxygenation-Induced GAPDH-Mediated Cell Death by Activating Akt/Nrf2 Signaling by Shimon Lecht, Adi Lahiani, Michal Klazas, Majdi Saleem Naamneh, Limor Rubin, Jiayi Dong, Wenhua Zheng, Philip Lazarovici

    Published in Biomedicines (2024-07-01)
    Get full text
    Article


  5. 5

    Dual biological treatments in immune-mediated disorders: a single center experience by Oded Shamriz, Elchanan Parnasa, Limor Rubin, Aviv Talmon, Yaarit Ribak, Isaam Hindi, Hagit Peleg, Ronit Confino-Cohen, Yuval Tal

    Published in BMC Immunology (2025-04-01)
    Get full text
    Article


  6. 6

    Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events by Michal Lotem, Limor Rubin, Aviv Talmon, Yaarit Ribak, David Lavie, Hovav Nechushtan, Nadia Caplan, Oded Shamriz, Irit Adini, Yuval Tal

    Published in Journal for ImmunoTherapy of Cancer (2024-10-01)
    Get full text
    Article


  7. 7

    Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome by Limor Rubin, Aviv Talmon, Yaarit Ribak, Asa Kessler, Yossi Martin, Tal Keidar Haran, Oded Shamriz, Oded Shamriz, Irit Adini, Yuval Tal

    Published in Frontiers in Immunology (2023-04-01)
    Get full text
    Article


  8. 8

    Benralizumab for adults with rare and off-label eosinophilic disorders: a 52-week prospective, single-center study by Aviv Talmon, Oded Shamriz, Oded Shamriz, Limor Rubin, Yaarit Ribak, Iris Aynor, Adam Nevo, Anna Elia, Meitav Ben Sion, Esther Forkosh, Alon Y. Hershko, Yuval Tal

    Published in Frontiers in Immunology (2025-10-01)
    Get full text
    Article


  9. 9

    Dupilumab for cancer-associated refractory pruritus by Aviv Talmon, MD, Shlomo Elias, MD, PhD, Limor Rubin, MD, Yaarit Ribak, MD, Eyal Ben Dori, MD, Oded Shamriz, MD, Michal Lotem, MD, Irit Adini, PhD, Yuval Tal, MD, PhD

    Get full text
    Article


  10. 10

    Clinical significance of very high IgE levels (≥1000 IU/mL): Population-based study of 118,211 adults by Shay Nemet, MD, Daniel Elbirt, MD, Ramon Cohen, MD, Keren Mahlab-Guri, MD, Shira Bezalel-Rosenberg, MD, Ilan Asher, MD, Aviv Talmon, MD, Limor Rubin, MD, Yaarit Ribak, MD, Ruslan Sergienko, MHA, Udi Nussinovitch, MD, PhD, Yuval Tal, MD, PhD, Oded Shamriz, MD

    Get full text
    Article


Search Tools: